[Federal Register Volume 85, Number 1 (Thursday, January 2, 2020)]
[Notices]
[Pages 112-113]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28294]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Commission on Childhood Vaccines 
(ACCV) will hold public meetings for the 2020 calendar year (CY). 
Information about ACCV, agendas, and materials for these meetings can 
be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.

DATES: ACCV meetings will be held on:
     March 5-6, 2020;
     June 4-5, 2020;
     September 3-4, 2020; and
     December 3-4, 2020.
    These meetings will be held from 9:00 a.m.-5:00 p.m. Eastern Time.

ADDRESSES: Meetings may be held in-person, by teleconference, and/or 
Adobe Connect webinar. In-person ACCV meetings will be held at 5600 
Fishers Lane, Rockville, Maryland 20857. Instructions for joining the 
meetings either in-person or remotely will be posted on the ACCV 
website 30 business days before the date of the meeting. For meeting 
information

[[Page 113]]

updates, go to the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/index.html.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury 
Compensation Programs, HRSA, 5600 Fishers Lane, 08N186B, Rockville, 
Maryland 20857; 301-443-6634; or [email protected].

SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations 
to the Secretary of HHS on policy, program development, and other 
issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP) and concerning other matters as described 
under section 2119 of the Public Health Service Act (42 U.S.C. 300aa-
19).
    Agenda items and meeting times are subject to change as priorities 
dictate. Refer to the ACCV website listed above for any meeting updates 
that may occur. For CY 2020 meetings, agenda items may include, but are 
not limited to updates from: (1) The Division of Injury Compensation 
Programs; (2) Department of Justice; (3) Office of Infectious Disease 
and HIV/AIDS Policy (HHS); (4) Immunization Safety Office (Centers for 
Disease Control and Prevention); (5) National Institute of Allergy and 
Infectious Diseases (National Institutes of Health); and, (6) Center 
for Biologics, Evaluation and Research (Food and Drug Administration). 
Refer to the ACCV website listed above for all current and updated 
information concerning the CY 2020 ACCV meetings, including draft 
agendas and meeting materials that will be posted 5 calendar days 
before the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting(s). Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to ACCV should be sent 
to Annie Herzog using the contact information above at least 5 business 
days before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Annie Herzog using the contact information 
listed above at least 10 business days before the meeting(s) they wish 
to attend. Since all in person meetings will occur in a federal 
government building, attendees must go through a security check to 
enter the building. Non-U.S. Citizen attendees must notify HRSA of 
their planned attendance at least 20 business days prior to the meeting 
in order to facilitate their entry into the building. All attendees are 
required to present government-issued identification prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2019-28294 Filed 12-31-19; 8:45 am]
 BILLING CODE 4165-15-P